Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study. [electronic resource]
Producer: 20160927Description: 3166-73 p. digitalISSN:- 1600-6143
- Adult
- Animals
- Antilymphocyte Serum -- immunology
- Biomarkers -- analysis
- Child
- Enzyme-Linked Immunosorbent Assay -- methods
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Graft Rejection -- diagnosis
- Graft Survival
- Humans
- Interferon-gamma -- analysis
- Kidney Failure, Chronic -- surgery
- Kidney Function Tests
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Postoperative Complications
- Prognosis
- Prospective Studies
- Rabbits
- Risk Factors
- Tissue Donors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.